Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NEWS

COVID drug drives viral mutations — and now some want to halt its use

Analysis reveals the signature of the antiviral drug molnupiravir in SARS-CoV-2 sequences riddled with mutations.
  1. Ewen Callaway
    View author publications

    You can also search for this author in PubMed  Google Scholar

A drug widely used to treat COVID-19 might be spurring the evolution of new SARS-CoV-2 variants.

Access options

Rent or buy this article

Get just this article for as long as you need it

$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 614, 399 (2023)

doi: https://doi.org/10.1038/d41586-023-00347-z

References

  1. Sanderson, T., Hisner, R., Donovan-Banfield, I., Peacock, T. & Ruis, C. Preprint at medRxiv https://doi.org/10.1101/2023.01.26.23284998 (2023).

  2. Rosenke, K. et al. Nature Commun. 12, 2295 (2021).

    Article  Google Scholar 

  3. Butler, C. C. et al. Lancet 401, 281–293 (2023).

    Article  Google Scholar 

Download references

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links